 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
Regulus Shares Hover Near IPO Price One Week After Going Public
October 11, 2012
Regulus Shares Hover Near IPO Price One Week After Going Public
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Regulus Prices IPO at $10-$12 a Share, Breaks out H1 '12 Financials
September 13, 2012 / Gene Silencing News - Regulus Files for Initial Public Offering
August 23, 2012 / Gene Silencing News - People in the News: William Rastetter, Carlo Croce, Tyler Jacks, Phillip Sharp
April 4, 2013 / Gene Silencing News - UNC Researchers Report New Details on Role of miR-122 in HCV
December 20, 2012 / Gene Silencing News - People in the News: Victor Knopov
November 29, 2012 / Gene Silencing News